Skip to main content
Article
Improvements in Work Productivity with up to 104 Weeks of Apremilast Monotherapy: Results from a Phase 3b, Randomized, Controlled Study in Biologic-NaiVe Subjects with Active Psoriatic Arthritis
Arthritis & Rheumatism (2017)
  • Philip J. Mease, University of Washington
  • Dafna D. Gladman, Toronto Western Hospital
  • Eric K. Davenport
  • Xiaolei Zhou
  • Benoit Guerette
  • Lichen Teng, Celgene
  • Satyin Kaura
  • Peter Nash, University of Queensland
Publication Date
October 1, 2017
Citation Information
Philip J. Mease, Dafna D. Gladman, Eric K. Davenport, Xiaolei Zhou, et al.. "Improvements in Work Productivity with up to 104 Weeks of Apremilast Monotherapy: Results from a Phase 3b, Randomized, Controlled Study in Biologic-NaiVe Subjects with Active Psoriatic Arthritis" Arthritis & Rheumatism Vol. 69 (2017)
Available at: http://works.bepress.com/philip-mease/30/